naloxone hydrochloride

AssetAlso called naloxone, NSC-70413, EN-15304, NSC-757109

Blocks opioid receptors, reversing opioid-mediated effects.

Stage
Approved
Modality
Small molecule
Target
OPRM1
14
Indications
125
Trials
4
Developers

Approved by the FDA on Apr 13, 1971 (NDA016636). 2 approvals stand. FDA

Indications

14

11 more

In the full profile

  • Target and mechanism4
  • Owner and partners5
  • Trials125
  • Evidence for its targets4
  • Competitors12
  • Signals15

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets